Boston Immune Technologies and Therapeutics (BITT)
Boston Immune Technologies and Therapeutics (BITT) is a biotech company in Winchester, United States.
- Headquarters
- Winchester, Massachusetts
- Business Model
- B2B
About
Boston Immune Technologies and Therapeutics (BITT) is a Boston, Massachusetts-based clinical-stage biotechnology company developing a novel class of antagonist antibodies, including its proprietary TrapMAb monoclonal antibodies, that target TNF superfamily receptors such as TNFR2 and CD40 for autoimmune and inflammatory diseases. The company has advanced its pipeline through partnerships, including a 2021 licensing agreement with BeiGene for TNFR2 antibodies and a 2024 collaboration with Otsuka's McQuade Center alongside new NIH funding for a TNFR2 clinical trial.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/boston-immune-technologies-and-therapeutics-bitt"><img src="https://indexed.vc/api/badge/company/boston-immune-technologies-and-therapeutics-bitt" alt="Boston Immune Technologies and Therapeutics (BITT) on Indexed.vc" width="260" height="76" /></a>